Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastases of Central Nervous System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01688713
What this trial is testing

Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasesNon-small Cell Lung Cancer
Zhejiang Cancer Hospital 20
Not applicableStudy completedNCT04539574
What this trial is testing

An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors

Who this might be right for
Central Nervous System NeoplasmGliomaMetastatic Malignant Neoplasm in the Central Nervous System+1 more
M.D. Anderson Cancer Center 50
Early research (Phase 1)Looking for participantsNCT02390518
What this trial is testing

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

Who this might be right for
Brain Metastases
University of Utah 86
Not applicableWithdrawnNCT01312506
What this trial is testing

Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls

Who this might be right for
Metastatic MelanomaCNS Metastases
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT00210652
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT00003878
What this trial is testing

Carmustine Implants in Treating Patients With Brain Metastases

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
New Approaches to Brain Tumor Therapy Consortium
Post-approval studies (Phase 4)UnknownNCT00201968
What this trial is testing

Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury

Who this might be right for
Spinal Cord Injury
Ontario Neurotrauma Foundation 32
Not applicableStudy completedNCT00660764
What this trial is testing

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

Who this might be right for
HypercholesterolemiaCoronary Heart DiseasePeripheral Vascular Disease+2 more
AstraZeneca
Large-scale testing (Phase 3)UnknownNCT02714010
What this trial is testing

EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Sun Yat-sen University 601
Very early researchActive Not RecruitingNCT03163368
What this trial is testing

Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors

Who this might be right for
Brain Metastases
Cedars-Sinai Medical Center 25
Not applicableLooking for participantsNCT07251868
What this trial is testing

Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study

Who this might be right for
Breast CancerBrain Metastases From Breast CancerTrop2
Peking University Cancer Hospital & Institute 100
Testing effectiveness (Phase 2)Ended earlyNCT01132664
What this trial is testing

Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer

Who this might be right for
Metastatic Breast CancerHER2+ Breast Cancer
Novartis Pharmaceuticals 72
Large-scale testing (Phase 3)Looking for participantsNCT06500481
What this trial is testing

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+2 more
NRG Oncology 115
Large-scale testing (Phase 3)Study completedNCT02636634
What this trial is testing

Non Invasive Methods for Differential Diagnosis Radionecrosis/Recurrence After Radiosurgery of Brain Metastases

Who this might be right for
Brain MetastasesGrowing Lesions After Radiosurgical Treatment
Assistance Publique - Hôpitaux de Paris 90
Early research (Phase 1)Study completedNCT00031928
What this trial is testing

Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 3,000
Large-scale testing (Phase 3)Ended earlyNCT03275402
What this trial is testing

131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases

Who this might be right for
NeuroblastomaCNS MetastasesLeptomeningeal Metastases
Y-mAbs Therapeutics 52
Not applicableNot Yet RecruitingNCT06811766
What this trial is testing

Comparative Effects of Strain-counterstrain and Muscle Energy Techniques on Neck Pain and Functional Disability in Patients with Cervicogenic Headache

Who this might be right for
Cervicogenic Headache
University of Faisalabad 54
Not applicableStudy completedNCT01624220
What this trial is testing

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Who this might be right for
Spinal Tumor
M.D. Anderson Cancer Center 41
Not applicableStudy completedNCT04170777
What this trial is testing

Perfexion Registration Using CBCT

Who this might be right for
Brain Metastases
University Health Network, Toronto 1,250
Testing effectiveness (Phase 2)Looking for participantsNCT05048212
What this trial is testing

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

Who this might be right for
Brain MetastasesRenal Cell Carcinoma
M.D. Anderson Cancer Center 20
Next Page